Experience with developing antibiotic stewardship programs in Serbia: potential model for other Balkan countries?
Abstract
Aim: Antimicrobial resistance and inappropriate use of antibiotics in children are important issues. Consequently, there is a need to develop comprehensive stewardship programs even in hospitals with limited resources starting with children's hospitals. Methods: Retrospective observational analysis of antimicrobial utilization and resistance patterns over 5 years in a tertiary care children's hospital in Serbia. Results: Cumulative antimicrobial resistance decreased but was still high, with high cumulative resistance rates among the most widely used antibiotics in the hospital. Total antibiotic use decreased from 2010 to 2014 although there was still high prescribing of reserved antibiotics. Conclusion: Concerns with inappropriate use and high resistance rates among some antibiotics used in the hospital are being used to develop guidance on future antibiotic use in this hospital, building on the recently introduced antibiotic stewardship program, as well as encourage other hospitals in Serbia to review their policies.
Formats available
You can view the full content in the following formats:
Supplementary Material
File (suppl_tables.docx)
- Download
- 96.93 KB
References
Papers of special note have been highlighted as: • of interest; •• of considerable interest
1.
Her Majesty's Government. Antimicrobial Resistance: Tackling a Crisis for the Health and Wealth of Nations. www.jpiamr.eu/wp-content/uploads/2014/12/AMR-Review-Paper-Tackling-a-crisis-for-the-health-and-wealth-of-nations_1–2.pdf
2.
Rezal RS, Hassali MA, Alrasheedy AA et al. Physicians’ knowledge, perceptions and behaviour towards antibiotic prescribing: a systematic review of the literature. Expert Rev. Anti-Infect. Ther. 13(5), 665–680 (2015).
• Good review paper discussing physicians’ knowledge and attitudes toward antibiotics.
3.
Laxminarayan R, Matsoso P, Pant S et al. Access to effective antimicrobials: a worldwide challenge. Lancet 387(10014), 168–175 (2016).
4.
Loeffler JM, Garbino J, Lew D et al. Antibiotic consumption, bacterial resistance and their correlation in a Swiss university hospital and its adult intensive care units. Scand. J. Infect. Dis. 35(11–12), 843–850 (2003).
5.
Frank U, Kleissle EM, Daschner FD et al. Multicentre study of antimicrobial resistance and antibiotic consumption among 6780 patients with bloodstream infections. Eur. J. Clin. Microbiol. Infect. Dis. 25(12), 815–817 (2006).
6.
Gandra S, Barter DM, Laxminarayan R. Economic burden of antibiotic resistance: how much do we really know? Clin. Microbiol. Infect. 20(10), 973–980 (2014).
7.
Oxford J, Kozlov R. Antibiotic resistance – a call to arms for primary healthcare providers. Int. J. Clin. Pract. Suppl. 180, 1–3 (2013).
8.
Laxminarayan R, Heymann DL. Challenges of drug resistance in the developing world. Brit. Med. J. 344, e1567 (2012).
9.
Earnshaw S, Mendez A, Monnet DL et al. Global collaboration to encourage prudent antibiotic use. Lancet Infect. Dis. 13(12), 1003–1004 (2013).
10.
Ganguly NK, Arora NK, Chandy SJ et al. Rationalizing antibiotic use to limit antibiotic resistance in India. Indian J. Med. Res. 134, 281–294 (2011).
11.
Laxminarayan R, Duse A, Wattal C et al. Antibiotic resistance – the need for global solutions. Lancet Infect. Dis. 13(12), 1057–1098 (2013).
12.
GRIPP. The Global Respiratory Infection Partnership. www.grip-initiative.org/about-the-partnership/partnerships-mission/the-grip-declaration/
13.
Baur D, Gladstone BP, Burkert F et al. Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis. Lancet Infect. Dis. 17(9), 990–1001 (2017).
• Good paper outlining the impact of a recent antibiotic stewardship program.
14.
Hulscher M, Prins JM. Antibiotic stewardship: does it work in hospital practice? A review of the evidence base. Clin. Microbiol. Infect. 23(11), 799–805 (2017).
• Good paper outlining antibiotic stwardship programs in practice in hospitals.
15.
Dyar OJ, Huttner B, Schouten J, Pulcini C. What is antimicrobial stewardship? Clin. Microbiol. Infect. 23(11), 793–798 (2017).
16.
Official Gazette of the Republic of Serbia. Rulebook of the criteria, manner and procedure for listing/delisting of reimbursement medicines in/from the list of medicines prescribed and dispensed under the compulsory health insurance coverage. No: 65/15, 71/15, 104/15.
17.
Official Gazette of the Republic of Serbia. Rulebook of the criteria, manner and procedure for listing/delisting of reimbursement medicines in/from the list of medicines prescribed and dispensed under the compulsory health insurance coverage. Nos: 24/16, 57/16, 61/16.
18.
Official Gazette of the Republic Serbia, No 12/2016.
19.
Official Gazette of the Republic Serbia, No 101/13.
20.
WHO Collaborating Centre for Drug statistics Methodology. Guidelines for ATC classification and DDD assignment (2015). www.whocc.no/filearchive/publications/2015_guidelines.pdf
21.
Versporten A, Bolokhovets G, Ghazaryan L et al. Antibiotic use in eastern Europe: a cross-national database study in coordination with the WHO Regional Office for Europe. Lancet Infect. Dis. 14(5), 381–387 (2014).
22.
Furst J, Cizman M, Mrak J et al. The influence of a sustained multifaceted approach to improve antibiotic prescribing in Slovenia during the past decade: findings and implications. Expert Rev. Anti-Infect. Ther. 13(2), 279–289 (2015).
23.
Bergman U, Risinggard H, Vlahovic-Palcevski V, Ericsson O. Use of antibiotics at hospitals in Stockholm: a benchmarking project using internet. Pharmacoepidemiol. Drug Saf. 13(7), 465–471 (2004).
24.
Vlahovic-Palcevski V, Gantumur M, Radosevic N et al. Coping with changes in the defined daily dose in a longitudinal drug consumption database. Pharmacy World Sci. 32(2), 125–129 (2010).
25.
WHO Collaborating Centre for Drug Statistics Methodology, Guidelines for ATC classification and DDD assignment 2016. Oslo, Norway (2016). www.whocc.no/filearchive/publications/2017_guidelines_web.pdf
26.
Goryachkina K, Babak S, Burbello A et al. Quality use of medicines: a new method of combining antibiotic consumption and sensitivity data-application in a Russian hospital. Pharmacoepidemiol. Drug Saf. 17, 636–644 (2008).
•• Good paper outlining a new methodology to review utilization patterns alongside resistance patterns to guide future care.
27.
Bozic B. Use of antibiotics in paediatric primary care settings in Serbia. Arch. Dis. Child. 100(10), 966–999 (2015).
•• Landmark paper in Serbia discussing antibiotic use in this important patient population.
28.
Cox JA, Vlieghe E, Mendelson M et al. Antibiotic stewardship in low-and middle-income countries: ‘same, but different’?Clin. Microbiol. Infect. 23(11), 812–818 (2017).
29.
Pulcini C. Antibiotic stewardship: update and perspectives. Clin. Microbiol. Infect. 23(11), 791–792 (2017).
30.
Araujo da Silva AR, Albernaz de Almeida Dias DC, Marques AF et al. The role of antimicrobial stewardship programmes in children: a systematic review. J. Hosp. Infect. (2017) (Epub ahead of print).
31.
Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disk susceptibility tests. Document M2-A9. Wayne, PA: CLSI; 20010.
32.
33.
Chitnis A, Wang R, Sun SX et al. Impact of initiation of asenapine on patterns of utilization and cost of healthcare resources associated with the treatment of bipolar I disorder. J. Med. Econ. 18(11), 863–870 (2015).
34.
Godman B, Petzold M, Bennett K et al. Can authorities appreciably enhance the prescribing of oral generic risperidone to conserve resources?: Findings from across Europe and their implications. BMC Med. 12, 98 (2014).
35.
Moon JC, Godman B, Petzold M et al. Different initiatives across Europe to enhance losartan utilization post generics: impact and implications. Front. Pharmacol. 5, 219 (2014).
36.
Schito GC, Georgopoulos A, Prieto J. Antibacterial activity of oral antibiotics against community-acquired respiratory pathogens from three European countries. J. Antimicrob. Chemother. 50(Suppl.), 7–11 (2002).
37.
38.
Kalaba M, Bajcetic M, Sipetic T et al. High rate of self purchasing of oral antibiotics in Serbia: implications for future policies. PPRI Vienna (2011). http://whocc.goeg.at/Downloads/Conference2011/PraesentationenPPRIKonferenz/general_PPRI%20conference%202011%20Abstract%20book.pdf
39.
Costelloe C, Metcalfe C, Lovering A et al. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. Brit. Med. J. 340, c2096 (2010).
•• Interesting paper discussing prescribing and resistance patterns in ambulatory care.
40.
Musher D, Dowell M, Shortridge VD et al. Emergence of macrolide resistance during treatment of pneumococcal pneumonia. N. Engl. J. Med. 346, 630–631 (2002).
41.
Van Kerkhoven D, Peetermans WE, Verbsit L, Verhaegen J. Breakthrough pneumococcal becteraemia in patients treated with clarithromycin or oral β-lactams. J. Antimicrob. Chemother. 51, 691–696 (2003).
42.
Bradley JS, Arguedas A, Blumer JL et al. Comparative study of levofloxacin in the treatment of children with community-acquired pneumonia. Pediatr. Infect. Dis. J. 26(10), 868–878 (2007).
43.
Kabra SK, Lodha R, Pandey RM. Antibiotics for community-acquired pneumonia in children. Cochrane Database Syst. Rev. (3), CD004874 (2010).
44.
Bradley JS, Kauffman RE, Balis DA et al. Assessment of musculoskeletal toxicity 5 years after therapy with levofloxacin. Pediatrics 134(1), E146–E153 (2014).
45.
Escola, Kilpi T, Palmu A et al. Efficacy of a pneumococcal conjugate vaccine against otitis media. N. Engl. J. Med. 344, 403–409 (2001).
46.
Mbelle N, Huebner RE, Wasas AD et al. Immunogenicity and impact on nasopharyngeal carriage of nonvalent pneumococcal conjugate vaccine. J. Infect. Dis. 180, 1171–1176 (1999).
47.
Black S, Shinefield H, Fireman D. Efficacy, safety and immunogenocity of heptavalent pneumococcal conjugate vaccine in children. Pediatr. Infect. Dis. J. 19, 187–115 (2000).
48.
Ramos NL, Dzung DT, Stopsack K et al. Characterisation of uropathogenic Escherichia coli from children with urinary tract infections in different countries. Eur. J. Clin. Microbial. Infect. Dis. 30, 1587–1593 (2011).
•• Landmark paper in this population to provide guidance on future care.
49.
Gupta K, Hooton TM, Naber KG et al. Infectious Diseases Society of America European Society for Microbiology and Infectious Diseases. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin. Infect. Dis. 52, E103–E120 (2011).
50.
Bryce A, Hay AJ, Lane I et al. Global prevalence of antibiotic resistance in paediatric urinary tract infections caused by Escherichia coli and association with routine use of antibiotics in primary care: systematic review and meta-analysis. Brit. Med. J. 352, i939 (2016).
51.
Lee S, Song Y, Cho SH, Kwon KT. Impact of extended-spectrum beta-lactamase on acute pyelonephritis treated with empirical ceftriaxone. Microb. Drug Resist. 20, 39–44 (2014).
• Well-conducted research discussing empiric use of ceftriaxone in this patient population.
52.
Herigon JC, Hersh AL, Gerber JS et al. Antibiotic management of Staphylococcus aureus infections in US Children's hospitals, 1999–2008. Pediatrics 125(6), e1294–e1300 (2010).
53.
Freeman J, Dawson L, Jowitt D et al. The impact of the Hand Hygiene New Zealand programme on hand hygiene practices in New Zealand's public hospitals. NZ Med. J. 129, 67–76 (2016).
54.
Hansen S, Zingg W, Ahmad R et al. Organization of infection control in European hospitals. J. Hosp. Infect. 91, 338–345 (2015).
55.
Storr JA, Engineer C, Allan V. Save lives: clean your hands: a WHO patient safety initiative for 2009. World Hosp. Health Serv. 45, 23–25 (2009).
56.
Llor C, Bjerrum L. Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem. Ther. Adv. Drug Saf. 5, 229–241 (2014).
57.
Viale P, Tumietto F, Giannella M et al. Impact of a hospital-wide multifaceted programme for reducing carbapenem-resistant Enterobacteriaceae infections in a large teaching hospital in northern Italy. Clin. Microbiol. Infect. 21, 242–247 (2015).
58.
Rocha-Pereira N, Lafferty N, Nathwani D. Educating healthcare professionals in antimicrobial stewardship: can online-learning solutions help? J. Antimicrob. Chemother. 70, 3175–3177 (2015).
59.
Zhang YZ, Singh S. Antibiotic stewardship programmes in intensive care units: why, how, and where are they leading us. World J. Crit. Care Med. 4, 13–28 (2015).
60.
Pollack LA, Srinivasan A. Core elements of hospital antibiotic stewardship programs from the Centers for Disease Control and Prevention. Clin. Infect. Dis. 59(Suppl. 3), S97–S100 (2014).
61.
Goff DA, Mendelson M. Antibiotic stewardship hits a home run for patients. Lancet Infect. Dis. 17(9), 892–893 (2017).
62.
Jankovic SM, Milovanovic D, RuzicZecevic D et al. Consulting clinical pharmacologist about treatment of inpatients in a tertiary hospital in Serbia. Eur. J. Clin. Pharmacol. 72(12), 1541–1543 (2016).
Information & Authors
Information
Published In
Copyright
© 2018 Future Medicine Ltd.
History
Received: 21 July 2017
Accepted: 26 October 2017
Published online: 21 February 2018
Keywords:
Topics
Authors
Metrics & Citations
Metrics
Article Usage
Article usage data only available from February 2023. Historical article usage data, showing the number of article downloads, is available upon request.
Citations
How to Cite
Experience with developing antibiotic stewardship programs in Serbia: potential model for other Balkan countries?. (2018) Journal of Comparative Effectiveness Research. DOI: 10.2217/cer-2017-0055
Export citation
Select the citation format you wish to export for this article or chapter.
Citing Literature
- Indrė Trečiokienė, ClaudiaGarciaSerpa Osorio‐de‐Castro, Aggregate‐level drug utilization analyses, Drug Utilization Research, 10.1002/9781119911685.ch14, (148-157), (2024).
- Ummara Altaf, Zikria Saleem, Muhammad Akhtar, Waleed Altowayan, Abdulmajeed Alqasoumi, Mohammed Alshammari, Abdul Haseeb, Fahad Raees, Mohammad Imam, Narjis Batool, Muhammad Akhtar, Brian Godman, Using Culture Sensitivity Reports to Optimize Antimicrobial Therapy: Findings and Implications of Antimicrobial Stewardship Activity in a Hospital in Pakistan, Medicina, 10.3390/medicina59071237, 59, 7, (1237), (2023).
- Yara-Natalie Abo, Bridget Freyne, Diana Kululanga, Penelope A. Bryant, The Impact of Antimicrobial Stewardship in Children in Low- and Middle-income Countries, Pediatric Infectious Disease Journal, 10.1097/INF.0000000000003317, 41, 3S, (S10-S17), (2022).
- PP Skosana, N Schellack, B Godman, A Kurdi, M Bennie, D Kruger, JC Meyer, A point prevalence survey of antimicrobial utilisation patterns and quality indices amongst hospitals in South Africa; findings and implications, Expert Review of Anti-infective Therapy, 10.1080/14787210.2021.1898946, 19, 10, (1353-1366), (2021).
- Zorana Kovacevic, Bojan Blagojevic, Jelena Suran, Olga Horvat, Mapping knowledge and comprehension of antimicrobial stewardship and biosecurity among veterinary students, PLOS ONE, 10.1371/journal.pone.0235866, 15, 8, (e0235866), (2020).
- Olga Horvat, Ana Tomas, Milica Paut Kusturica, Dragica Bukumiric, Bojan Blagojevic, Zorana Kovacevic, Serbian students’ knowledge, attitudes and behaviour towards antibiotic use: is there room for improvement?, International Journal of Public Health, 10.1007/s00038-020-01448-6, 65, 8, (1257-1267), (2020).
- Zikria Saleem, Mohamed Azmi Hassali, Brian Godman, Ann Versporten, Furqan Khurshid Hashmi, Hamid Saeed, Fahad Saleem, Muhammad Salman, Inayat Ur Rehman, Tahir Mehmood Khan, Point prevalence surveys of antimicrobial use: a systematic review and the implications, Expert Review of Anti-infective Therapy, 10.1080/14787210.2020.1767593, 18, 9, (897-910), (2020).
- Radmila Popović, Zdenko Tomić, Ana Tomas, Nada Anđelić, Sanja Vicković, Gordana Jovanović, Dragica Bukumirić, Olga Horvat, Ana Sabo, Five-year surveillance and correlation of antibiotic consumption and resistance of Gram-negative bacteria at an intensive care unit in Serbia, Journal of Chemotherapy, 10.1080/1120009X.2020.1755588, 32, 6, (294-303), (2020).
- Jane Robertson, Kotoji Iwamoto, Iris Hoxha, Lilit Ghazaryan, Vafa Abilova, Ana Cvijanovic, Halina Pyshnik, Marina Darakhvelidze, Larissa Makalkina, Arianit Jakupi, Aigul Dzhakubekova, Angela Carp, Lidija Cizmovic, Svetlana Rachina, Vesela Radonjic, Salomudin Yusufi, Mesil Aksoy, Muhabbat Ibragimova, Brian Godman, Hans Kluge, Hanne Bak Pedersen, Antimicrobial Medicines Consumption in Eastern Europeand Central Asia – An Updated Cross-National Study and Assessment of QuantitativeMetrics for Policy Action, Frontiers in Pharmacology, 10.3389/fphar.2018.01156, 9, (2019).